{
    "xml": "<topic id=\"PHP1875\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/mometasone-furoate\" basename=\"mometasone-furoate\" title=\"MOMETASONE FUROATE\">\n<title>MOMETASONE FUROATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_968\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/mometasone\">Mometasone</xref>\n</p>\n<data name=\"vtmid\">75203002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34650\" title=\"CORTICOSTEROIDS (INHALED)\" namespace=\"/drug-classes/corticosteroids-inhaled\">CORTICOSTEROIDS (INHALED)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34550\" title=\"CORTICOSTEROIDS (TOPICAL)\" namespace=\"/drug-classes/corticosteroids-topical\">CORTICOSTEROIDS (TOPICAL)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34648\" title=\"CORTICOSTEROIDS (INTRANASAL)\" namespace=\"/drug-classes/corticosteroids-intranasal\">CORTICOSTEROIDS (INTRANASAL)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">   </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP74327\" outputclass=\"indicationsAndDose\" rev=\"1.51\" parent=\"/drugs/mometasone-furoate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of powder</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 400&#8239;micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200&#8239;micrograms once daily, if control maintained.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 400&#8239;micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200&#8239;micrograms once daily, if control maintained.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of severe asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of powder</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Increased if necessary up to 400&#8239;micrograms twice daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Increased if necessary up to 400&#8239;micrograms twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids</p>\n<p outputclass=\"therapeuticIndication\">Psoriasis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>Apply once daily, to be applied thinly (to scalp in case of lotion).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply once daily, to be applied thinly (to scalp in case of lotion).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis and treatment of allergic rhinitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>50&#8239;micrograms daily, dose to be sprayed into each nostril.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>100&#8239;micrograms daily, increased if necessary up to 200&#8239;micrograms daily, dose to be sprayed into each nostril; reduced to 50&#8239;micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8239;micrograms daily, increased if necessary up to 200&#8239;micrograms daily, dose to be sprayed into each nostril; reduced to 50&#8239;micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nasal polyps</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 100&#8239;micrograms daily for 5&#8211;6 weeks, dose to be sprayed into each nostril, then increased if necessary to 100&#8239;micrograms twice daily, dose to be sprayed into each nostril, consider alternative treatment if no improvement after further 5&#8211;6 weeks, reduce to the lowest effective dose when control achieved.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"potency\">\n<title>Potency</title>\n<p>Mometasone furoate 0.1% cream, ointment, and scalp lotion: potent.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP74284\" outputclass=\"unlicensedUse\" rev=\"1.7\" parent=\"/drugs/mometasone-furoate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use in children</p>\n<p>Not licensed for use in children under 2 years.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP74298\" outputclass=\"sideEffects\" rev=\"1.26\" parent=\"/drugs/mometasone-furoate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by inhalation</p>\n<p>\n<ph outputclass=\"sideEffect\">headache</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by inhalation</p>\n<p>\n<ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">weight gain</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Nasal ulceration</p>\n<p>Nasal ulceration occurs commonly with preparations containing mometasone furoate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP74314\" outputclass=\"patientAndCarerAdvice\" rev=\"1.26\" parent=\"/drugs/mometasone-furoate\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Mometasone furoate inhaler for asthma prevention (prophylaxis)</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis\">www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis</xref>\n</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\r\n</p>\r\n<p>Patients or carers should be given advice on how to administer mometasone by inhaler. With high doses, a steroid card should be supplied.</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\r\n<p>Patients and carers should be advised on the application of topical mometasone. </p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP74264\" outputclass=\"nationalFunding\" rev=\"1.9\" parent=\"/drugs/mometasone-furoate\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>The <i>Scottish Medicines Consortium</i> has advised (November 2003) that <i>Asmanex</i>\n<tm tmtype=\"reg\"/> is restricted for use following failure of first-line inhaled corticosteroids.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1875-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/mometasone-furoate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: ointment</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76136\" title=\"Inhalation powder\" namespace=\"/drugs/mometasone-furoate/inhalation-powder\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76124\" title=\"Liquid\" namespace=\"/drugs/mometasone-furoate/liquid\">Liquid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76118\" title=\"Cream\" namespace=\"/drugs/mometasone-furoate/cream\">Cream</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76143\" title=\"Ointment\" namespace=\"/drugs/mometasone-furoate/ointment\">Ointment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76128\" title=\"Spray\" namespace=\"/drugs/mometasone-furoate/spray\">Spray</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78318\" namespace=\"/treatment-summaries/airways-disease-use-of-corticosteroids\" title=\"Airways disease, use of corticosteroids\" count=\"1\" rel=\"backlink\">Airways disease, use of corticosteroids</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_968\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/mometasone\" title=\"Mometasone\" count=\"1\" rel=\"link\">Mometasone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34650\" namespace=\"/drug-classes/corticosteroids-inhaled\" title=\"CORTICOSTEROIDS (INHALED)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (INHALED)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34550\" namespace=\"/drug-classes/corticosteroids-topical\" title=\"CORTICOSTEROIDS (TOPICAL)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (TOPICAL)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34648\" namespace=\"/drug-classes/corticosteroids-intranasal\" title=\"CORTICOSTEROIDS (INTRANASAL)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (INTRANASAL)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76136\" namespace=\"/drugs/mometasone-furoate/inhalation-powder\" title=\"Inhalation powder\" count=\"1\" rel=\"link\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76124\" namespace=\"/drugs/mometasone-furoate/liquid\" title=\"Liquid\" count=\"1\" rel=\"link\">Liquid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76118\" namespace=\"/drugs/mometasone-furoate/cream\" title=\"Cream\" count=\"1\" rel=\"link\">Cream</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76143\" namespace=\"/drugs/mometasone-furoate/ointment\" title=\"Ointment\" count=\"1\" rel=\"link\">Ointment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76128\" namespace=\"/drugs/mometasone-furoate/spray\" title=\"Spray\" count=\"1\" rel=\"link\">Spray</xref>\n</links>\n</topic>",
    "id": "PHP1875",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/mometasone-furoate",
    "basename": "mometasone-furoate",
    "title": "MOMETASONE FUROATE",
    "interactants": [
        {
            "id": "bnf_int_968",
            "label": "Mometasone"
        }
    ],
    "vtmid": "75203002",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (INHALED)",
        "CORTICOSTEROIDS (TOPICAL)",
        "CORTICOSTEROIDS (INTRANASAL)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of asthma",
                        "html": "Prophylaxis of asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of powder"
                    ],
                    "textContent": "By inhalation of powder",
                    "html": "By inhalation of powder"
                },
                "child": [
                    {
                        "textContent": "Initially 400 micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200 micrograms once daily, if control maintained.",
                        "html": "<p>Initially 400&#8239;micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200&#8239;micrograms once daily, if control maintained.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 400 micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200 micrograms once daily, if control maintained.",
                        "html": "<p>Initially 400&#8239;micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200&#8239;micrograms once daily, if control maintained.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of severe asthma",
                        "html": "Prophylaxis of severe asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of powder"
                    ],
                    "textContent": "By inhalation of powder",
                    "html": "By inhalation of powder"
                },
                "child": [
                    {
                        "textContent": "Increased if necessary up to 400 micrograms twice daily.",
                        "html": "<p>Increased if necessary up to 400&#8239;micrograms twice daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Increased if necessary up to 400 micrograms twice daily.",
                        "html": "<p>Increased if necessary up to 400&#8239;micrograms twice daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids",
                        "html": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids"
                    },
                    {
                        "textContent": "Psoriasis",
                        "html": "Psoriasis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply once daily, to be applied thinly (to scalp in case of lotion).",
                        "html": "<p>Apply once daily, to be applied thinly (to scalp in case of lotion).</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply once daily, to be applied thinly (to scalp in case of lotion).",
                        "html": "<p>Apply once daily, to be applied thinly (to scalp in case of lotion).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis and treatment of allergic rhinitis",
                        "html": "Prophylaxis and treatment of allergic rhinitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "child": [
                    {
                        "textContent": "50 micrograms daily, dose to be sprayed into each nostril.",
                        "html": "<p>50&#8239;micrograms daily, dose to be sprayed into each nostril.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "100 micrograms daily, increased if necessary up to 200 micrograms daily, dose to be sprayed into each nostril; reduced to 50 micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.",
                        "html": "<p>100&#8239;micrograms daily, increased if necessary up to 200&#8239;micrograms daily, dose to be sprayed into each nostril; reduced to 50&#8239;micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "100 micrograms daily, increased if necessary up to 200 micrograms daily, dose to be sprayed into each nostril; reduced to 50 micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.",
                        "html": "<p>100&#8239;micrograms daily, increased if necessary up to 200&#8239;micrograms daily, dose to be sprayed into each nostril; reduced to 50&#8239;micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Nasal polyps",
                        "html": "Nasal polyps"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "adult": [
                    {
                        "textContent": "Initially 100 micrograms daily for 5&#8211;6 weeks, dose to be sprayed into each nostril, then increased if necessary to 100 micrograms twice daily, dose to be sprayed into each nostril, consider alternative treatment if no improvement after further 5&#8211;6 weeks, reduce to the lowest effective dose when control achieved.",
                        "html": "<p>Initially 100&#8239;micrograms daily for 5&#8211;6 weeks, dose to be sprayed into each nostril, then increased if necessary to 100&#8239;micrograms twice daily, dose to be sprayed into each nostril, consider alternative treatment if no improvement after further 5&#8211;6 weeks, reduce to the lowest effective dose when control achieved.</p>"
                    }
                ]
            }
        ],
        "potency": [
            {
                "type": "potency",
                "title": "Potency",
                "textContent": "Mometasone furoate 0.1% cream, ointment, and scalp lotion: potent.",
                "html": "<p>Mometasone furoate 0.1% cream, ointment, and scalp lotion: potent.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With topical use in children",
                    "html": "With <ph outputclass=\"route\">topical</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Not licensed for use in children under 2 years.",
                "html": "<p>Not licensed for use in children under 2 years.</p>"
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "weight gain",
                        "html": "weight gain",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Nasal ulceration",
                "textContent": "Nasal ulceration occurs commonly with preparations containing mometasone furoate.",
                "html": "<p>Nasal ulceration occurs commonly with preparations containing mometasone furoate.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis",
                        "label": "www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Mometasone furoate inhaler for asthma prevention (prophylaxis)",
                "textContent": "www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis\">www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis</xref>\n</p>"
            },
            {
                "type": "patientResources",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Patients or carers should be given advice on how to administer mometasone by inhaler. With high doses, a steroid card should be supplied.",
                "html": "<p>Patients or carers should be given advice on how to administer mometasone by inhaler. With high doses, a steroid card should be supplied.</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Patients and carers should be advised on the application of topical mometasone.",
                "html": "<p>Patients and carers should be advised on the application of topical mometasone. </p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "When used by inhalation The Scottish Medicines Consortium has advised (November 2003) that Asmanex is restricted for use following failure of first-line inhaled corticosteroids.",
                "html": "<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> </p> <p>The <i>Scottish Medicines Consortium</i> has advised (November 2003) that <i>Asmanex</i> <tm tmtype=\"reg\"/> is restricted for use following failure of first-line inhaled corticosteroids.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "ointment"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76136",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76124",
                "label": "Liquid",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76118",
                "label": "Cream",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76143",
                "label": "Ointment",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76128",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78318",
                "label": "Airways disease, use of corticosteroids",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_968",
                "label": "Mometasone",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34650",
                "label": "CORTICOSTEROIDS (INHALED)",
                "type": "drugClass"
            },
            {
                "id": "PHP34550",
                "label": "CORTICOSTEROIDS (TOPICAL)",
                "type": "drugClass"
            },
            {
                "id": "PHP34648",
                "label": "CORTICOSTEROIDS (INTRANASAL)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76136",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76124",
                "label": "Liquid",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76118",
                "label": "Cream",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76143",
                "label": "Ointment",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76128",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    }
}